| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/16/2001 | CA2400583A1 Porcine reproductive and respiratory syndrome virus and methods of use |
| 08/16/2001 | CA2400497A1 Methods and compositions for generating angiostatin |
| 08/16/2001 | CA2400472A1 Il-17 like molecules and uses thereof |
| 08/16/2001 | CA2400299A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | CA2399945A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399839A1 Protein design automation for protein libraries |
| 08/16/2001 | CA2399769A1 Inhibitors of apoptosis |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399566A1 Par4 peptides and polypeptides |
| 08/16/2001 | CA2399452A1 Use of neuregulin-.beta. as an indicator and/or target |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399388A1 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399266A1 Improved galactosylation of recombinant glycoproteins |
| 08/16/2001 | CA2399135A1 Compounds for detection of infection by chlamydophila abortus |
| 08/16/2001 | CA2399126A1 Extraction of zein protein from gluten meal |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398571A1 Materials and methods for treating ocular-related disorders |
| 08/16/2001 | CA2398483A1 Human neurexin-like proteins and polynucleotides encoding the same |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2397369A1 Interferon-alpha induced genes |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/16/2001 | CA2392450A1 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | CA2392070A1 Novel invertase inhibitors and methods of use |
| 08/15/2001 | CN1308740A Methods of determining protein activity levels usne expression profiles |
| 08/15/2001 | CN1308680A Genomic sequences upstream of the coding region of the G-CSF gene for protein production and delivery |
| 08/15/2001 | CN1308679A Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 08/15/2001 | CN1308678A Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use |
| 08/15/2001 | CN1308677A Human tumour-derived polyptde hormone phosphatonin |
| 08/15/2001 | CN1308674A Multivalent T cell receptor complexes |
| 08/15/2001 | CN1308673A Modifing the expression of the FSH beta gene by homologous recombination |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308636A Method for purifying hemoglobin |
| 08/15/2001 | CN1308544A Treatment for diabetes |
| 08/15/2001 | CN1308543A Oxidized thymosin beta 4 |
| 08/15/2001 | CN1308127A Expression carrier for recombinant human B lymphocyte stimulating factor and its construction process |
| 08/15/2001 | CN1308124A Preparation and application of antibiotic peptide beer yeast |
| 08/15/2001 | CN1308123A Preparation and application of antibiotic peptide pichia yeast |
| 08/15/2001 | CN1308087A Human testis specific protein gene coding protein |
| 08/15/2001 | CN1308086A Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 08/15/2001 | CN1307900A Application of tigroid spider toxic extract in preparing analgesic |
| 08/15/2001 | CN1069649C [B9 glutamic acid, B10 aspartic acid] human insulin |
| 08/14/2001 | US6274789 Rice gene resistant to blast disease |
| 08/14/2001 | US6274788 Bicistronic DNA construct comprising X-myc transgene for use in production of transgenic animal model systems for human hepatocellular carcinoma and transgenic animal model systems so produced |
| 08/14/2001 | US6274722 Expression of a foamy virus envelope protein |
| 08/14/2001 | US6274721 Toxins active against pests |
| 08/14/2001 | US6274720 Human preproneurotensin/neuromedin N |
| 08/14/2001 | US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis |
| 08/14/2001 | US6274712 Muteins; cell division potent stimulators or superagonists; useful angiogenesis, wound healing, treating ischemia, gastric or duodenal ulcer, neural injury |
| 08/14/2001 | US6274711 Proteins and mimetics which function in regulating, controlling physiology, development, and differentiation of mammalian immune cells including hemopoietic type; cytotoxic t lymphocyte activated or associated antigen (ctla) |
| 08/14/2001 | US6274710 Antibodies which specifically bind T Cell inducible factors (TIFs) |
| 08/14/2001 | US6274709 By immunocompetent cells of high molecular weight; at residue 70 is methionine or threonine, antigens for monoclonal antibodies; increases cytotoxicity of killer cells |
| 08/14/2001 | US6274708 Mouse interleukin-11 receptor |
| 08/14/2001 | US6274707 Protein sweetener |
| 08/14/2001 | US6274706 Intron/exon of the human and mouse beta 3-adrenergic receptor genes |
| 08/14/2001 | US6274704 Peptides derived from the heparin binding domain of fibronectin |
| 08/14/2001 | US6274703 Method of cell surface activation and inhibition |
| 08/14/2001 | US6274702 Bone stimulating factor |
| 08/14/2001 | US6274558 Purified hypothalamic inhibitory factor |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274554 Method for preventing and treating hearing loss using a neurturin protein product |
| 08/14/2001 | US6274549 Administering genetically engineered human insulin with deletion or substitution |
| 08/14/2001 | US6274548 Pectic substance as a growth factor stabilizer |
| 08/14/2001 | US6274380 Cacnglike3 polynucleotides and expression systems |
| 08/14/2001 | US6274376 An isolated polynucleotide encoding an atp depentent protease; therapy and diagnosis of respiratory diseases, central nervous systems disorders, septic arthritis, skin disorders and toxic shock syndrome |
| 08/14/2001 | US6274365 A carrier compound containing an active recombinant furin enzyme; gene therapy; treatment of cancer |
| 08/14/2001 | US6274362 RGS-containing molecules and uses thereof |
| 08/14/2001 | US6274361 A polynucleotide encoding a polypeptide sequence for a peptidyl-trna hydrolase; diagnosis and therapy for staphylococcal infections; screening antibiotics, vaccines |
| 08/14/2001 | US6274354 Methods using cre-lox for production of recombinant adeno-associated viruses |
| 08/14/2001 | US6274350 Dna sequences which encode enzymes of defined amino acid sequences; for efficient recombinant production |
| 08/14/2001 | US6274348 Methods for the preparation of positively charged proteins |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274345 Expression vectors encoding Escherichia coli OmpC as a cell surface anchoring motif |
| 08/14/2001 | US6274344 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides |
| 08/14/2001 | US6274342 Nucleotide sequence; diagnosis; antiinflammatory agents; recombinant culture production |
| 08/14/2001 | US6274341 Culturing cell that has been genetically engineered to inducibly express a tumor suppressor gene product to arrest cell proliferation, then recovering desired product from cell |
| 08/14/2001 | US6274339 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/14/2001 | US6274333 Type-2 neurotensin receptor (NT-R2) |
| 08/14/2001 | US6274332 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 08/14/2001 | US6274331 Using recombinant dna vectors which encode di-alpha or di-beta globin-like polypeptide having linker, transforming cells, screening for production by determining response to carbon monoxide, determining amino acid sequence of linker |
| 08/14/2001 | US6274330 L-AP4 sensitive glutamate receptors |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274312 Genetically engineered nucleotide sequences which code modulators of cell proliferation; for treatment of cell proliferation defects |
| 08/14/2001 | US6274311 Isolated nucleic acid encoding a eukaryotic malate permease from schizosaccharomyces pombe which mediates the uptake of l-malate, succinate, and malonate; fermenation of wine |
| 08/14/2001 | US6274307 Immunologically active peptides or polypeptides from the parvovirus B19 |
| 08/14/2001 | US6274279 Preparations of bacteriorhodopsin variants having increased memory time, and their use |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |
| 08/14/2001 | US6274147 Preparing cdna of infectious pancreatic necrosis virus genome, initiating replication of ds rna in host cell using rna derived from cdna, incubating host cell in culture medium, and isolating live, infectious pancreatic necrosis virus |
| 08/14/2001 | US6274146 Biologically active phytogenous proteoglycan and a method of making thereof |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274142 Neutralizing coagulant activity of tissue factor by administering antibody which binds to tissue factor protein and neutralizes |
| 08/14/2001 | US6274139 For therapy of bacterial infections |
| 08/14/2001 | US6274136 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274121 Superparamagnetic particles, process for their manufacture and use |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | US6273598 Computer system and methods for producing morphogen analogs of human OP-1 |
| 08/14/2001 | CA2258567C Maize promoter sequence for leaf- and stalk-preferred gene expression |